David F Burgstahler Insider Trading $ORGO Organogenesis Holdings Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David F Burgstahler.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David F Burgstahler. David F Burgstahler is Director in ANGIODYNAMICS INC ($ANGO) and Director in Warner Chilcott plc ($WCRX) and Director in Lantheus Holdings, Inc. ($LNTH) and in INC Research Holdings, Inc. ($INCR) and Director in INC Research Holdings, Inc. ($INCR) and President & CEO in Organogenesis Holdings Inc. ($AHPA) and Director in WideOpenWest, Inc. ($WOW) and Director in Osmotica Pharmaceuticals plc ($OSMT).
David F Burgstahler in Organogenesis Holdings Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David F Burgstahler: President & CEO
Holdings: 9,022,741 shares
Current Value: $89,144,681
Latest Transaction: Dec 12 2018
$ORGO Market Capitalization: $74.25M
$ORGO Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David F Burgstahler in Organogenesis Holdings Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANGO, LNTH, ORGO, OSMT, INCR, WCRX, WOW
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Option Exercise | A | 0.00 | 4,100,000 | 0 | 4,100,000 | |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Option Exercise | D | 0.00 | 3,247,668 | 0 | 1,048,691 | |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Grant | A | 0.00 | 6,538,732 | 0 | 15,561,473 | 9 M to 15.6 M (+72.47 %) |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Grant | A | 0.00 | 9,022,741 | 0 | 9,022,741 | 0 to 9 M |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Option Exercise | A | 0.00 | 4,100,000 | 0 | 4,100,000 | |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Option Exercise | D | 0.00 | 3,247,668 | 0 | 1,048,691 | |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Grant | A | 0.00 | 6,538,732 | 0 | 15,561,473 | 9 M to 15.6 M (+72.47 %) |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Grant | A | 0.00 | 9,022,741 | 0 | 9,022,741 | 0 to 9 M |
Page: 1